Pan‐cancer multi‐omics analysis revealed significant correlations between TP53 mutation status, intratumoral microbiome diversity (particularly in HCC and EC) and altered tumour microenvironment (TME) components, such as reduced endothelial cell abundance. The gene discussed is TP53; the disease is cancer.